Your browser doesn't support javascript.
loading
Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells.
Hamzeloo-Moghadam, Maryam; Aghaei, Mahmoud; Abdolmoham Madi, Mohammad Hossein; Fallahian, Faranak.
  • Hamzeloo-Moghadam M; Traditional Medicine and Materia Medica Research Center; Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Aghaei M; Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Abdolmoham Madi MH; Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
  • Fallahian F; Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
J Cancer Res Ther ; 15(5): 1105-1108, 2019.
Article en En | MEDLINE | ID: mdl-31603118

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sesquiterpenos / Neoplasias de la Mama / Regulación hacia Abajo / Ciclina D1 / Quinasa 4 Dependiente de la Ciclina / Lactonas Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sesquiterpenos / Neoplasias de la Mama / Regulación hacia Abajo / Ciclina D1 / Quinasa 4 Dependiente de la Ciclina / Lactonas Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article